Cargando…
CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status
Cancer stem cells (CSCs) play a critical role in the initiation, progression and therapy relapse of many cancers including non-small cell lung cancer (NSCLC). Here, we aimed to address the question of whether the FACS-sorted CSC-like (CD44 + &CD133 +) vs. non-CSC (CD44−/CD133− isogenic subpopula...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101266/ https://www.ncbi.nlm.nih.gov/pubmed/35563313 http://dx.doi.org/10.3390/ijms23094922 |
_version_ | 1784707043995680768 |
---|---|
author | Pustovalova, Margarita Blokhina, Taisia Alhaddad, Lina Chigasova, Anna Chuprov-Netochin, Roman Veviorskiy, Alexander Filkov, Gleb Osipov, Andreyan N. Leonov, Sergey |
author_facet | Pustovalova, Margarita Blokhina, Taisia Alhaddad, Lina Chigasova, Anna Chuprov-Netochin, Roman Veviorskiy, Alexander Filkov, Gleb Osipov, Andreyan N. Leonov, Sergey |
author_sort | Pustovalova, Margarita |
collection | PubMed |
description | Cancer stem cells (CSCs) play a critical role in the initiation, progression and therapy relapse of many cancers including non-small cell lung cancer (NSCLC). Here, we aimed to address the question of whether the FACS-sorted CSC-like (CD44 + &CD133 +) vs. non-CSC (CD44−/CD133− isogenic subpopulations of p53wt A549 and p53null H1299 cells differ in terms of DNA-damage signaling and the appearance of “dormant” features, including polyploidy, which are early markers (predictors) of their sensitivity to genotoxic stress. X-ray irradiation (IR) at 5 Gy provoked significantly higher levels of the ATR-Chk1/Chk2-pathway activity in CD44−/CD133− and CD133+ subpopulations of H1299 cells compared to the respective subpopulations of A549 cells, which only excited ATR-Chk2 activation as demonstrated by the Multiplex DNA-Damage/Genotoxicity profiling. The CD44+ subpopulations did not demonstrate IR-induced activation of ATR, while significantly augmenting only Chk2 and Chk1/2 in the A549- and H1299-derived cells, respectively. Compared to the A549 cells, all the subpopulations of H1299 cells established an increased IR-induced expression of the γH2AX DNA-repair protein. The CD44−/CD133− and CD133+ subpopulations of the A549 cells revealed IR-induced activation of ATR-p53-p21 cell dormancy signaling-mediated pathway, while none of the CD44+ subpopulations of either cell line possessed any signs of such activity. Our data indicated, for the first time, the transcription factor MITF–FAM3C axis operative in p53-deficient H1299 cells, specifically their CD44+ and CD133+ populations, in response to IR, which warrants further investigation. The p21-mediated quiescence is likely the predominant surviving pathway in CD44−/CD133− and CD133+ populations of A549 cells as indicated by single-cell high-content imaging and analysis of Ki67- and EdU-coupled fluorescence after IR stress. SA-beta-galhistology revealed that cellular-stress-induced premature senescence (SIPS) likely has a significant influence on the temporary dormant state of H1299 cells. For the first time, we demonstrated polyploid giant and/or multinucleated cancer-cell (PGCC/MGCC) fractions mainly featuring the progressively augmenting Ki67(low) phenotype in CD44+ and CD133+ A549 cells at 24–48 h after IR. In contrast, the Ki67(high) phenotype enrichment in the same fractions of all the sorted H1299 cells suggested an increase in their cycling/heterochromatin reorganization activity after IR stress. Our results proposed that entering the “quiescence” state rather than p21-mediated SIPS may play a significant role in the survival of p53wt CSC-like NSCLC cells after IR. The results obtained are important for the selection of therapeutic schemes for the treatment of patients with NSCLC, depending on the functioning of the p53 system in tumor cells. |
format | Online Article Text |
id | pubmed-9101266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91012662022-05-14 CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status Pustovalova, Margarita Blokhina, Taisia Alhaddad, Lina Chigasova, Anna Chuprov-Netochin, Roman Veviorskiy, Alexander Filkov, Gleb Osipov, Andreyan N. Leonov, Sergey Int J Mol Sci Article Cancer stem cells (CSCs) play a critical role in the initiation, progression and therapy relapse of many cancers including non-small cell lung cancer (NSCLC). Here, we aimed to address the question of whether the FACS-sorted CSC-like (CD44 + &CD133 +) vs. non-CSC (CD44−/CD133− isogenic subpopulations of p53wt A549 and p53null H1299 cells differ in terms of DNA-damage signaling and the appearance of “dormant” features, including polyploidy, which are early markers (predictors) of their sensitivity to genotoxic stress. X-ray irradiation (IR) at 5 Gy provoked significantly higher levels of the ATR-Chk1/Chk2-pathway activity in CD44−/CD133− and CD133+ subpopulations of H1299 cells compared to the respective subpopulations of A549 cells, which only excited ATR-Chk2 activation as demonstrated by the Multiplex DNA-Damage/Genotoxicity profiling. The CD44+ subpopulations did not demonstrate IR-induced activation of ATR, while significantly augmenting only Chk2 and Chk1/2 in the A549- and H1299-derived cells, respectively. Compared to the A549 cells, all the subpopulations of H1299 cells established an increased IR-induced expression of the γH2AX DNA-repair protein. The CD44−/CD133− and CD133+ subpopulations of the A549 cells revealed IR-induced activation of ATR-p53-p21 cell dormancy signaling-mediated pathway, while none of the CD44+ subpopulations of either cell line possessed any signs of such activity. Our data indicated, for the first time, the transcription factor MITF–FAM3C axis operative in p53-deficient H1299 cells, specifically their CD44+ and CD133+ populations, in response to IR, which warrants further investigation. The p21-mediated quiescence is likely the predominant surviving pathway in CD44−/CD133− and CD133+ populations of A549 cells as indicated by single-cell high-content imaging and analysis of Ki67- and EdU-coupled fluorescence after IR stress. SA-beta-galhistology revealed that cellular-stress-induced premature senescence (SIPS) likely has a significant influence on the temporary dormant state of H1299 cells. For the first time, we demonstrated polyploid giant and/or multinucleated cancer-cell (PGCC/MGCC) fractions mainly featuring the progressively augmenting Ki67(low) phenotype in CD44+ and CD133+ A549 cells at 24–48 h after IR. In contrast, the Ki67(high) phenotype enrichment in the same fractions of all the sorted H1299 cells suggested an increase in their cycling/heterochromatin reorganization activity after IR stress. Our results proposed that entering the “quiescence” state rather than p21-mediated SIPS may play a significant role in the survival of p53wt CSC-like NSCLC cells after IR. The results obtained are important for the selection of therapeutic schemes for the treatment of patients with NSCLC, depending on the functioning of the p53 system in tumor cells. MDPI 2022-04-28 /pmc/articles/PMC9101266/ /pubmed/35563313 http://dx.doi.org/10.3390/ijms23094922 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pustovalova, Margarita Blokhina, Taisia Alhaddad, Lina Chigasova, Anna Chuprov-Netochin, Roman Veviorskiy, Alexander Filkov, Gleb Osipov, Andreyan N. Leonov, Sergey CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status |
title | CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status |
title_full | CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status |
title_fullStr | CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status |
title_full_unstemmed | CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status |
title_short | CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status |
title_sort | cd44+ and cd133+ non-small cell lung cancer cells exhibit dna damage response pathways and dormant polyploid giant cancer cell enrichment relating to their p53 status |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101266/ https://www.ncbi.nlm.nih.gov/pubmed/35563313 http://dx.doi.org/10.3390/ijms23094922 |
work_keys_str_mv | AT pustovalovamargarita cd44andcd133nonsmallcelllungcancercellsexhibitdnadamageresponsepathwaysanddormantpolyploidgiantcancercellenrichmentrelatingtotheirp53status AT blokhinataisia cd44andcd133nonsmallcelllungcancercellsexhibitdnadamageresponsepathwaysanddormantpolyploidgiantcancercellenrichmentrelatingtotheirp53status AT alhaddadlina cd44andcd133nonsmallcelllungcancercellsexhibitdnadamageresponsepathwaysanddormantpolyploidgiantcancercellenrichmentrelatingtotheirp53status AT chigasovaanna cd44andcd133nonsmallcelllungcancercellsexhibitdnadamageresponsepathwaysanddormantpolyploidgiantcancercellenrichmentrelatingtotheirp53status AT chuprovnetochinroman cd44andcd133nonsmallcelllungcancercellsexhibitdnadamageresponsepathwaysanddormantpolyploidgiantcancercellenrichmentrelatingtotheirp53status AT veviorskiyalexander cd44andcd133nonsmallcelllungcancercellsexhibitdnadamageresponsepathwaysanddormantpolyploidgiantcancercellenrichmentrelatingtotheirp53status AT filkovgleb cd44andcd133nonsmallcelllungcancercellsexhibitdnadamageresponsepathwaysanddormantpolyploidgiantcancercellenrichmentrelatingtotheirp53status AT osipovandreyann cd44andcd133nonsmallcelllungcancercellsexhibitdnadamageresponsepathwaysanddormantpolyploidgiantcancercellenrichmentrelatingtotheirp53status AT leonovsergey cd44andcd133nonsmallcelllungcancercellsexhibitdnadamageresponsepathwaysanddormantpolyploidgiantcancercellenrichmentrelatingtotheirp53status |